 |
|
 |
| |
 |
|
Class Information
Number: 435/339.1
Name: Chemistry: molecular biology and microbiology > Animal cell, per se (e.g., cell lines, etc.); composition thereof; process of propagating, maintaining or preserving an animal cell or composition thereof; process of isolating or separating an animal cell or composition thereof; process of preparing a composition containing an animal cell; culture media therefore > Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof > Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.) > Binds a virus or component or product thereof (e.g., virus associated antigen, etc.) > Binds a retrovirus or component or product thereof (e.g., hiv, lav, htlv, etc.)
Description: Subject matter involving an animal cell which produces a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an integral or isolated part of a retrovirus, or with a substance shed by a retrovirus, such as a viral antigen.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7625566 |
Anti-idiotypic monoclonal antibody reactive with HIV neutralizing antibody 2F5 |
Dec. 1, 2009 |
| 7595049 |
IGG1 monoclonal antibody with anti-HIV neutralizing activity |
Sep. 29, 2009 |
| 7442550 |
Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
Oct. 28, 2008 |
| 7223844 |
Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by Env-CD4-co-receptor complexes |
May. 29, 2007 |
| 7189826 |
Monoclonal human natural antibodies |
Mar. 13, 2007 |
| 7056735 |
Mimetics and inhibitors of the interaction between Vpr (HIV viral protein of regulation) and ANT (Mitochondrial adenine nucleotide translocator) |
Jun. 6, 2006 |
| 7041293 |
HIV env antibodies |
May. 9, 2006 |
| 6949337 |
Cellular receptor for HIV-1 Vpr essential for G2/M phase transition of the cell cycle |
Sep. 27, 2005 |
| 6927023 |
Method of identifying modulators of HIV-1 Vpu and Gag interaction with U binding protein (Ubp) |
Aug. 9, 2005 |
| 6908734 |
Sulfated CCR5 peptides for HIV-1 infection |
Jun. 21, 2005 |
| 6893813 |
Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy |
May. 17, 2005 |
| 6821744 |
Method, assay, and kit for quantifying HIV protease inhibitors |
Nov. 23, 2004 |
| 6821723 |
GP41 antigen |
Nov. 23, 2004 |
| 6818392 |
Monoclonal antibodies to human immunodeficiency virus and uses thereof |
Nov. 16, 2004 |
| 6815201 |
HIV-1 gp120 V1/V2 domain epitopes capable of generating neutralizing antibodies |
Nov. 9, 2004 |
| 6812025 |
Two hybrid assay that detects HIV-1 reverse transcriptase dimerization |
Nov. 2, 2004 |
| 6812026 |
Antibodies directed against binding-associated epitopes |
Nov. 2, 2004 |
| 6783939 |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines |
Aug. 31, 2004 |
| 6733993 |
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications |
May. 11, 2004 |
| 6709811 |
Versatile reagent for detecting murine leukemia viruses |
Mar. 23, 2004 |
| 6703019 |
Cationized antibodies against intracellular proteins |
Mar. 9, 2004 |
| 6696291 |
Synthetic HIV gag genes |
Feb. 24, 2004 |
| 6670181 |
Compositions and methods for treating viral infections |
Dec. 30, 2003 |
| 6670466 |
Human endogenous retrovirus in breast cancer |
Dec. 30, 2003 |
| 6653130 |
Method for the development of an HIV vaccine |
Nov. 25, 2003 |
| 6649409 |
Method for producing a nucleotide sequence construct with optimized codons for an HIV genetic vaccine based on a primary, early HIV isolate and synthetic envelope BX08 constructs |
Nov. 18, 2003 |
| 6649410 |
Method for the development of an HIV vaccine |
Nov. 18, 2003 |
| 6605427 |
Assay for detection of viral fusion inhibitors |
Aug. 12, 2003 |
| 6551824 |
Retrovirus from the HIV group and its use |
Apr. 22, 2003 |
| 6498006 |
Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy |
Dec. 24, 2002 |
| 6482614 |
Stress proteins and uses therefor |
Nov. 19, 2002 |
| 6479284 |
Humanized antibody and uses thereof |
Nov. 12, 2002 |
| 6465173 |
Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease |
Oct. 15, 2002 |
| 6448375 |
Active and inactive CC-chemokine receptor |
Sep. 10, 2002 |
| 6448078 |
Cellular receptor for HIV-1 Vpr essential for G2/M phase transition of the cell cycle |
Sep. 10, 2002 |
| 6432714 |
Prophylactic and therapeutic method |
Aug. 13, 2002 |
| 6410318 |
Antibodies directed against binding-associated epitopes |
Jun. 25, 2002 |
| 6406911 |
Compositions and methods for sensitive detection of HIV infection and monitoring of drug resistance |
Jun. 18, 2002 |
| 6403300 |
Monoclonal antibodies for detection of friend murine leukemia virus |
Jun. 11, 2002 |
| 6391635 |
Monoclonal human natural antibodies |
May. 21, 2002 |
| 6392015 |
Method of identifying modulators of HIV-1 Vpu and Gag interaction with U binding protein (Ubp) |
May. 21, 2002 |
| 6383806 |
Method for the development of an HIV vaccine |
May. 7, 2002 |
| 6379957 |
Methods for HIV sequencing and genotyping |
Apr. 30, 2002 |
| 6365404 |
Hematopoietic cell method for treatment of HIV infection |
Apr. 2, 2002 |
| 6333163 |
Method of facilitating HIV-1 infection through human leukotriene B4 receptor |
Dec. 25, 2001 |
| 6329202 |
Antibodies directed against binding associated epitopes |
Dec. 11, 2001 |
| 6309880 |
Antibodies specific for CD4-binding domain of HIV-1 |
Oct. 30, 2001 |
| 6291239 |
Monoclonal antibody |
Sep. 18, 2001 |
| 6287568 |
Methods relating to immunogenic dextran-protein conjugates |
Sep. 11, 2001 |
| 6284536 |
Modified immunoglobin molecules and methods for use thereof |
Sep. 4, 2001 |
|
|
|
 |
|
 |
|
| |
Randomly Featured Patents |
|
